research Topical Spironolactone in the Treatment of Evaporative Dry Eye Disease 1 citations, June 2023 in “Cureus” Spironolactone may help improve symptoms and tear quality in dry eye disease.
research The RELIEF Study: Tolerability and Efficacy of Preservative-Free Latanoprost in the Treatment of Glaucoma or Ocular Hypertension 22 citations, March 2019 in “European Journal of Ophthalmology” Preservative-free latanoprost effectively lowers eye pressure with fewer side effects.
research Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease 2 citations, September 2023 in “Curēus” Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.
research Hypertrichosis Induced by Latanoprost 39 citations, April 2001 in “Journal of The American Academy of Dermatology” Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.
research Instilled Bimatoprost Ophthalmic Solution in Patients with Eyelash Alopecia Areata 30 citations, August 2009 in “Journal of the American Academy of Dermatology” Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.